Fol. Biol. 2021, 67, 37-47
https://doi.org/10.14712/fb2021067010037
Investigation of the Inhibitory Effect of Platycodin D in Human Transitional Cell Carcinoma Cell Line 5637
References
1. , M., Böhle, A., Burger, M., Capoun, O., Cohen, D., Compérat, E. M., Hernández, V., Kaasinen, E., Palou, J., Rouprêt, M., van Rhijn, B. W. G., Shariat, S. F., Soukup, V., Sylvester, R. J., Zigeuner, R. (2017) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur. Urol. 71, 447-461.
<https://doi.org/10.1016/j.eururo.2016.05.041>
2. , L., Bahmad, H. F., Araji, T., Al Choboq, J., Bou-Gharios, J., Cheaito, K., Zeidan, Y. H., Eid, T., Geara, F., Abou- Kheir, W. (2019) Assessing radiosensitivity of bladder cancer in vitro: a 2D vs. 3D approach. Front. Oncol. 9, 153.
<https://doi.org/10.3389/fonc.2019.00153>
3. , J., Jackson, P. K., Kirschner, M. W., Dutta, A. (1995) Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 374, 386-388.
<https://doi.org/10.1038/374386a0>
4. , T., Gao, J., Xiang, P., Chen, Y., Ji, J., Xie, P., Wu, H., Xiao, W., Wei, Y., Wang, S., Lan, L., Ji, H., Yan, T. (2015) Protective effect of platycodin D on liver injury in alloxaninduced diabetic mice via regulation of Treg/Th17 balance. Int. Immunopharmacol. 26, 338-348.
<https://doi.org/10.1016/j.intimp.2015.04.001>
5. , M. L., Hewitt, R. E., Kleiner, D. E., Jr., Stetler-Stevenson, W. G. (1996) MMP-2: expression, activation and inhibition. Enzyme Protein 49, 7-19.
<https://doi.org/10.1159/000468613>
6. , L. Y., Nguyen, V. T., Farber, J. L., Huebner, K., Magee, P. N. (2000) Early deregulation of the p16ink4a-cyclin D1/ cyclin-dependent kinase 4-retinoblastoma pathway in cell proliferation-driven esophageal tumorigenesis in zinc-deficient rats. Cancer Res. 60, 4589-4595.
7. , J., Lemke, H., Baisch, H., Wacker, H. H., Schwab, U., Stein, H. (1984) Cell cycle analysis of a cell proliferationassociated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol. 133, 1710-1715.
<https://doi.org/10.4049/jimmunol.133.4.1710>
8. , J. L., Litwin, M. S., Lai, J., Yano, E. M., Madison, R., Setodji, C., Adams, J. L., Saigal, C. S. (2010) Use of radical cystectomy for patients with invasive bladder cancer. J. Natl. Cancer Inst. 102, 802-811.
<https://doi.org/10.1093/jnci/djq121>
9. , D., Kroemer, G. (1998) The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol. 8, 267-271.
<https://doi.org/10.1016/S0962-8924(98)01273-2>
10. , M., Maryam, A., Zhang, H., Mehmood, T., Ma, T. (2016) Killing cancer with platycodin D through multiple mechanisms. J. Cell. Mol. Med. 20, 389-402.
<https://doi.org/10.1111/jcmm.12749>
11. , M. O., Moon, D. O., Choi, Y. H., Shin, D. Y., Kang, H. S., Choi, B. T., Lee, J. D., Li, W., Kim, G. Y. (2008) Platycodin D induces apoptosis and decreases telomerase activity in human leukemia cells. Cancer Lett. 261, 98-107.
<https://doi.org/10.1016/j.canlet.2007.11.010>
12. , T. W., Song, I. B., Lee, H. K., Lim, J. H., Cho, E. S., Son, H. Y., Park, S. J., Kim, J. W., Yun, H. I. (2012) Platycodin D, a triterpenoid sapoinin from Platycodon grandiflorum, ameliorates cisplatin-induced nephrotoxicity in mice. Food Chem. Toxicol. 50, 4254-4259.
<https://doi.org/10.1016/j.fct.2012.05.022>
13. , J. L., Ramachandiran, S., Bernal-Mizrachi, L. (2015) A time to kill: targeting apoptosis in cancer. Int. J. Mol. Sci. 16, 2942-2955.
<https://doi.org/10.3390/ijms16022942>
14. , V., Stanley, K., Stjernswärd, J., Mott, K. (1987) Bladder cancer: approaches to prevention and control. Bull. World Health Organ. 65, 513-520.
15. , T., Döller, C., Quehenberger, F., Stranzl-Lawatsch, H., Langsenlehner, U., Pummer, K., Kapp, K. S. (2010) Treatment results of radiation therapy for muscleinvasive bladder cancer. Strahlenther. Onkol. 186, 203-209.
<https://doi.org/10.1007/s00066-010-2053-1>
16. , T., Tang, Z. H., Xu, W. S., Wu, G. S., Wang, Y. F., Chang, L. L., Zhu, H., Chen, X. P., Wang, Y. T., Chen, Y., Lu, J. J. (2015a) Platycodin D triggers autophagy through activation of extracellular signal-regulated kinase in hepatocellular carcinoma HepG2 cells. Eur. J. Pharmacol. 749, 81-88.
<https://doi.org/10.1016/j.ejphar.2015.01.003>
17. , T., Xu, X. H., Tang, Z. H., Wang, Y. F., Leung, C. H., Ma, D. L., Chen, X. P., Wang, Y. T., Chen, Y., Lu, J. J. (2015b) Platycodin D induces apoptosis and triggers ERK- and JNK-mediated autophagy in human hepatocellular carcinoma BEL-7402 cells. Acta Pharmacol. Sin. 36, 1503-1513.
<https://doi.org/10.1038/aps.2015.99>
18. , T., Chen, X., Chen, X., Ma, D. L., Leung, C. H., Lu, J. J. (2016) Platycodin D potentiates proliferation inhibition and apoptosis induction upon AKT inhibition via feedback blockade in non-small cell lung cancer cells. Sci. Rep. 6, 37997.
<https://doi.org/10.1038/srep37997>
19. , X., Yang, W., Sun, S. (2018) Platycodin D induces apoptosis of human transitional cell carcinoma 5637 cell lines and related molecular mechanism. Cancer Res. Prev. Treat. 45, 634-639.
20. , X., Gao, Y. G., Guan, Y. Y., Xu, J. R., Lu, Q., Zhao, M., Liu, Y. R., Liu, H. J., Fang, C., Chen, H. Z. (2014) Platycodin D inhibits tumor growth by antiangiogenic activity via blocking VEGFR2-mediated signaling pathway. Toxicol. Appl. Pharmacol. 281, 118-124.
<https://doi.org/10.1016/j.taap.2014.09.009>
21. , M. M., Kim, H. R., Xing, R., Hsiao, S., Mammoto, A., Chen, J., Serbanovic-Canic, J., Feng, S., Bowden, N. P., Maguire, R., Ariaans, M., Francis, S. E., Weinberg, P. D., van der Heiden, K., Jones, E. A., Chico, T. J., Ridger, V., Evans, P. C. (2016) TWIST1 integrates endothelial responses to flow in vascular dysfunction and atherosclerosis. Circ. Res. 119, 450-462.
<https://doi.org/10.1161/CIRCRESAHA.116.308870>
22. , M. C., Metts, J. C., Milito, S. J., Thomas, C. R., Jr. (2000) Bladder cancer: a review of diagnosis and management. J. Natl. Med. Assoc. 92, 285-294.
23. , D. I., Lee, J. H., Moon, S. K., Kim, C. H., Lee, Y. T., Cheong, J., Choi, B. T., Choi, Y. H. (2005) Induction of apoptosis and inhibition of telomerase activity by aqueous extract from Platycodon grandiflorum in human lung carcinoma cells. Pharmacol. Res. 51, 437-443.
<https://doi.org/10.1016/j.phrs.2004.11.003>
24. , J. C., Citrin, D. E., Agarwal, P. K., Apolo, A. B. (2014a) Multimodal management of muscle-invasive bladder cancer. Curr. Probl. Cancer 38, 80-108.
<https://doi.org/10.1016/j.currproblcancer.2014.06.001>
25. , J. C., Lee, Y. J., Choi, H. Y., Shin, Y. K., Kim, J. D., Ku, S. K. (2014b) In vivo and in vitro antitumor effects of platycodin d, a saponin purified from Platycodi radix on the H520 lung cancer cell. J. Evid. Based Complementary Altern. Med. 2014, 478653.
26. , C. M., Singh, A. T. K. (2018) Apoptosis: a target for anticancer therapy. Int. J. Mol. Sci. 19, 448.
<https://doi.org/10.3390/ijms19020448>
27. , K., Gollapudi, K., King, C., Steinberg, M. L., Chin, A. I. (2014) Bladder preservation in the treatment of muscleinvasive bladder cancer. Bladder 1, e5.
<https://doi.org/10.14440/bladder.2014.37>
28. , T., Gerdes, J. (2000) The Ki-67 protein: from the known and the unknown. J. Cell. Physiol. 182, 311-322.
<https://doi.org/10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9>
29. , R., Thalmann, G. N., Rotzer, D., Perren, A., Fleischmann, A. (2013) CCND1/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response. Mod. Pathol. 27, 87-95.
<https://doi.org/10.1038/modpathol.2013.125>
30. , S., Dorstyn, L., Dawar, S., Kumar, S. (2015) Old, new and emerging functions of caspases. Cell Death Differ. 22, 526-539.
<https://doi.org/10.1038/cdd.2014.216>
31. , R. L., Miller, K. D., Jemal, A. (2019) Cancer statistics, 2019. CA Cancer J. Clin. 69, 7-34.
<https://doi.org/10.3322/caac.21551>
32. , T. T., Ko, J., Gudena, V. K., Verma, N., Chaudhary, U. B. (2014) Chemotherapeutic and targeted biological agents for metastatic bladder cancer: a comprehensive review. Int. J. Urol. 21, 630-637.
<https://doi.org/10.1111/iju.12407>
33. , D., Rathore, K., Cekanova, M. (2016) Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancer. Drug Des. Devel. Ther. 10, 3305-3322.
<https://doi.org/10.2147/DDDT.S112113>
34. , H. Y., Deng, X. H., Yuan, G. Y., Hou, X. F., Zhu, Z. D., Zhou, L., Ren, M. X. (2014) Expression of bcl-2 and p53 in induction of esophageal cancer cell apoptosis by ECRG2 in combination with cisplatin. Asian Pac. J. Cancer Prev. 15, 1397-1401.
<https://doi.org/10.7314/APJCP.2014.15.3.1397>
35. , R. J., van der Meijden, A. P., Oosterlinck, W., Witjes, J. A., Bouffioux, C., Denis, L., Newling, D. W., Kurth, K. (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur. Urol. 49, 466-465; discussion 475-467.
<https://doi.org/10.1016/j.eururo.2005.12.031>
36. , Z. H., Li, T., Gao, H. W., Sun, W., Chen, X. P., Wang, Y. T., Lu, J. J. (2014) Platycodin D from Platycodonis radix enhances the anti-proliferative effects of doxorubicin on breast cancer MCF-7 and MDA-MB-231 cells. Chin. Med. 9, 16.
<https://doi.org/10.1186/1749-8546-9-16>
37. , D. B., Siref, L. E., Feloney, M. P., Hauke, R. J., Agrawal, D. K. (2015) Immunological basis in the pathogenesis and treatment of bladder cancer. Expert Rev. Clin. Immunol. 11, 265-279.
<https://doi.org/10.1586/1744666X.2015.983082>
38. , H., Wang, H., Makki, M. S., Wen, J., Dai, Y., Shi, Q., Liu, Q., Zhou, X., Wang, J. (2014) Overexpression of β-catenin and cyclin D1 predicts a poor prognosis in ovarian serous carcinomas. Int. J. Clin. Exp. Pathol. 7, 264-271.
39. , X., Lai, Y., Hua, Z. C. (2019) Apoptosis and apoptotic body: disease message and therapeutic target potentials. Biosci. Rep. 39, BSR20180992.
<https://doi.org/10.1042/BSR20180992>
40. , J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., Weinberg, R. A. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927-939.
<https://doi.org/10.1016/j.cell.2004.06.006>
41. , J. S., Kim, A. K. (2010) Platycodin D induces apoptosis in MCF-7 human breast cancer cells. J. Med. Food 13, 298-305.
<https://doi.org/10.1089/jmf.2009.1226>
42. , C. C., Zhang, C., Yao, J. H., Lai, S. H., Han, B. J., Li, W., Tang, B., Wan, D., Liu, Y. J. (2016) Platycodin D induced apoptosis and autophagy in PC-12 cells through mitochondrial dysfunction pathway. Spectrochim. Acta A 168, 199-205.
<https://doi.org/10.1016/j.saa.2016.06.005>
43. , H. L., Kim, Y. S. (2004) Determination of the kinetic properties of platycodin D for the inhibition of pancreatic lipase using a 1,2-diglyceride-based colorimetric assay. Arch. Pharm. Res. 27, 1048-1052.
<https://doi.org/10.1007/BF02975430>
44. , H., Zhang, S., Xu, D., Lee, M. Y., Zhang, Z., Lee, E. Y., Darzynkiewicz, Z. (2014) Expression of the p12 subunit of human DNA polymerase δ (Pol δ), CDK inhibitor p21(WAF1), Cdt1, cyclin A, PCNA and Ki-67 in relation to DNA replication in individual cells. Cell Cycle 13, 3529-3540.
<https://doi.org/10.4161/15384101.2014.958910>
45. , R., Chen, M., Jiang, Z., Zhao, F., Xi, B., Zhang, X., Fu, H., Zhou, K. (2015) Platycodin-D induced autophagy in non-small cell lung cancer cells via PI3K/Akt/mTOR and MAPK signaling pathways. J. Cancer 6, 623-631.
<https://doi.org/10.7150/jca.11291>
46. , R., Lu, Z., Liu, K., Guo, J., Liu, J., Zhou, Y., Yang, J., Mi, M., Xu, H. (2015) Platycodin D induces tumor growth arrest by activating FOXO3a expression in prostate cancer in vitro and in vivo. Curr. Cancer Drug Targets 14, 860-871.
<https://doi.org/10.2174/1568009614666141128104642>
